![Bärbel Brumme-Bothe](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Bärbel Brumme-Bothe
Voorzitter bij Max-Delbrück-Centrum für Molekulare Medizin (MDC)
Actieve functies van Bärbel Brumme-Bothe
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
Germany Ministry of Education & Research | Corporate Officer/Principal | - | - |
Max-Delbrück-Centrum für Molekulare Medizin (MDC)
![]() Max-Delbrück-Centrum für Molekulare Medizin (MDC) Miscellaneous Commercial ServicesCommercial Services Max-Delbrück-Centrum für Molekulare Medizin operates as a biomedical research institute. It engages in translating discoveries from molecular research into applications to improve the prevention, diagnosis, and treatment of major human diseases. The company was founded in 1992 and is headquartered in Berlin, Germany. | Voorzitter | - | - |
Loopbaan van Bärbel Brumme-Bothe
Eerdere bekende functies van Bärbel Brumme-Bothe
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
German Cancer Research Center
![]() German Cancer Research Center Hospital/Nursing ManagementHealth Services German Cancer Research Center offers biomedical research services. It develops novel approaches to make tumor diagnosis more precise and for a treatment of cancer. The firm provides different research programs such as cell and tumor biology, functional and structural genomics, risk factors and prevention, tumor immunology, imaging and radio oncology, and translational cancer research. The company was founded in 1964 and is headquartered in Heidelberg, Germany. | Voorzitter | - | - |
Helmholtz-Zentrum für Infektionsforschung GmbH
![]() Helmholtz-Zentrum für Infektionsforschung GmbH BiotechnologyHealth Technology Helmholtz-Zentrum für Infektionsforschung GmbH provides bio-medical research and development services. The firm engages in research projects focused on infection biology and its clinical application and practical implementation. It also specializes in the examination of pathogens that are either medically relevant or that can be used as models for the research of infections. Its research topics encompass bacterial and viral pathogens, immune response, and anti-infectives. The company was founded in 1965 and is headquartered in Braunschweig, Germany. | Voorzitter | - | - |
Statistieken
Internationaal
Duitsland | 5 |
Operationeel
Chairman | 3 |
Corporate Officer/Principal | 1 |
Sectoraal
Health Technology | 2 |
Government | 2 |
Commercial Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Bedrijven in privébezit | 4 |
---|---|
Helmholtz-Zentrum für Infektionsforschung GmbH
![]() Helmholtz-Zentrum für Infektionsforschung GmbH BiotechnologyHealth Technology Helmholtz-Zentrum für Infektionsforschung GmbH provides bio-medical research and development services. The firm engages in research projects focused on infection biology and its clinical application and practical implementation. It also specializes in the examination of pathogens that are either medically relevant or that can be used as models for the research of infections. Its research topics encompass bacterial and viral pathogens, immune response, and anti-infectives. The company was founded in 1965 and is headquartered in Braunschweig, Germany. | Health Technology |
Germany Ministry of Education & Research | Government |
Max-Delbrück-Centrum für Molekulare Medizin (MDC)
![]() Max-Delbrück-Centrum für Molekulare Medizin (MDC) Miscellaneous Commercial ServicesCommercial Services Max-Delbrück-Centrum für Molekulare Medizin operates as a biomedical research institute. It engages in translating discoveries from molecular research into applications to improve the prevention, diagnosis, and treatment of major human diseases. The company was founded in 1992 and is headquartered in Berlin, Germany. | Commercial Services |
German Cancer Research Center
![]() German Cancer Research Center Hospital/Nursing ManagementHealth Services German Cancer Research Center offers biomedical research services. It develops novel approaches to make tumor diagnosis more precise and for a treatment of cancer. The firm provides different research programs such as cell and tumor biology, functional and structural genomics, risk factors and prevention, tumor immunology, imaging and radio oncology, and translational cancer research. The company was founded in 1964 and is headquartered in Heidelberg, Germany. | Health Services |
- Beurs
- Insiders
- Bärbel Brumme-Bothe
- Ervaring